Name (Synonyms) | Correlation | |
---|---|---|
drug902 | Extracorporeal membrane oxygenation Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D013577 | Syndrome NIH | 0.11 |
D055371 | Acute Lung Injury NIH | 0.10 |
D012127 | Respiratory Distress Syndrome, Newborn NIH | 0.10 |
D012128 | Respiratory Distress Syndrome, Adult NIH | 0.09 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
Prospective observational trial in patients admitted to ICU diagnosed with COVID-19 requiring invasive mechanical ventilation. Characterization of Reverse Triggering asynchrony during the first 5 days of invasive mechanical ventilation and other asynchronies, and its correlation with different outcomes.
Description: To analyze the incidence of Reverse Triggering in the initial phases of invasive mechanical ventilation in COVID-19 patients
Measure: Incidence and pattern of presentation of Reverse triggering in COVID-19 patients under invasive mechanical ventilation Time: during the 5 first days of invasive mechanical ventilationDescription: To correlate the presence of Reverse Triggering with the level of sedation and use of neuromuscular blockers
Measure: Incidence of Reverse Triggering related to the level of sedation in COVID-19 patients under invasive mechanical ventilation Time: From the day of mechanical ventilation initation up to 5 days or the last day of mechanical ventilationDescription: To analyze the incidence of breath stacking and ineffective efforts secondary to RT.
Measure: Reverse triggering and secondary asynchronies in COVID-19 patients under invasive mechanical ventilation Time: From the day of mechanical ventilation initiation up to 5 daysDescription: To analyze the incidence of RT, ineffective efforts and double triggering throughout the period of invasive mechanical ventilation
Measure: Incidence and pattern of presentation of asynchronies in COVID-19 patients under invasive mechanical ventilation Time: Each day from the day of mechanical ventilation initiation until the day of mechanical ventilation withdrawal or up to 28 daysDescription: To correlate the presence of asycnhronies and its type with duration of invasive mechanical ventilation, ICU length of stay and survival
Measure: Influence of asynchronies in different outcomes in in COVID-19 patients under invasive mechanical ventilation Time: Each day from the day of mechanical ventilation initiation until the end of invasive mechanical ventilation, ICU discharge and hospital discharge or up to 28 days